We use necessary cookies to make our website work. We'd also like to use optional cookies to understand how you use it, and to help us improve it.

For more information, please read our cookie policy.


Medication for benign prostatic hypertrophy

ACCEPTABLE MEDICATION

SELECTIVE ALPHA BLOCKERS

Tamsulosin

400MCG OD

Alfuzosin

10MG OD

5 ALPHA-REDUCTASE ENZYME INHIBITORS

Finasteride

5MG OD

Dutasteride

500MCG OD

ACTION

Grounded for a minimum period of 2 weeks after starting medication or an increase in dose. Grounded for 48 hours after first dose of medication.

INVESTIGATIONS

Ensure satisfactory symptom control and free of side-effects of medication e.g. headache, dizziness (especially on standing), palpitations, blurred vision.

AND

AME/GP to document three separate sets of lying and standing blood pressures to confirm no postural hypotension.

Ensure satisfactory symptom control and free of side-effects of medication that may affect ability to fly e.g. hypersensitivity reactions, testicular pain.

CERTIFICATION

CLASS 1 & 2 UNRESTRICTED

CLASS 1 & 2 UNRESTRICTED

ADDITIONAL NOTES

  1. Once daily formulations permitted only.
  2. Combination Therapy: an alpha blocker prescribed together with a 5 alpha-reductase enzyme inhibitor is acceptable for unrestricted Class 1 or 2 certification, following the alpha blocker policy above.